La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Wellell Performance dei guadagni passati

Il passato criteri di controllo 2/6

Wellell ha registrato una crescita degli utili a un tasso medio annuo di 11%, mentre il settore Medical Equipment ha registrato utili in crescita a un tasso medio annuo di 11.2%. I ricavi sono stati in crescita a un tasso medio annuo di 7.1%. Il ritorno sul capitale proprio di Wellell è 4.7% e ha margini netti di 4.5%.

Informazioni chiave

11.0%

Tasso di crescita degli utili

10.8%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore	11.5%
Tasso di crescita dei ricavi	7.1%
Rendimento del capitale proprio	4.7%
Margine netto	4.5%
Ultimo aggiornamento sui guadagni	30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Mar 23

Recent updates

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Mar 29

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Mar 01

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Feb 11

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Jan 27

Is Apex Medical (TPE:4106) Using Too Much Debt?

Jan 12

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Dec 28

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Nov 27

Ripartizione dei ricavi e delle spese

Come Wellell guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

TWSE:4106 Ricavi, spese e utili (TWD Millions )
Data	Ricavi	Guadagni	Spese G+A	Spese di R&S
30 Jun 24	2,475	112	793	169
31 Mar 24	2,594	141	771	164
31 Dec 23	2,647	152	778	166
30 Sep 23	2,665	145	775	158
30 Jun 23	2,792	181	774	159
31 Mar 23	2,768	181	759	159
31 Dec 22	2,664	161	728	154
30 Sep 22	2,585	150	727	156
30 Jun 22	2,492	121	721	154
31 Mar 22	2,389	104	735	153
31 Dec 21	2,374	102	732	151
30 Sep 21	2,310	109	705	146
30 Jun 21	2,236	106	681	163
31 Mar 21	2,168	126	619	167
31 Dec 20	2,004	105	581	168
30 Sep 20	1,967	110	549	164
30 Jun 20	1,924	95	539	147
31 Mar 20	1,938	58	566	140
31 Dec 19	2,036	88	587	138
30 Sep 19	2,088	104	610	133
30 Jun 19	2,100	118	612	132
31 Mar 19	2,122	123	614	134
31 Dec 18	2,106	108	608	132
30 Sep 18	2,049	93	601	146
30 Jun 18	2,122	90	612	148
31 Mar 18	2,119	115	612	142
31 Dec 17	2,089	118	614	139
30 Sep 17	2,103	114	609	127
30 Jun 17	1,967	117	594	115
31 Mar 17	1,951	102	610	108
31 Dec 16	1,990	123	616	103
30 Sep 16	1,994	153	619	100
30 Jun 16	1,983	143	627	99
31 Mar 16	2,008	158	605	96
31 Dec 15	2,016	169	597	95
30 Sep 15	2,029	144	653	90
30 Jun 15	2,165	175	682	89
31 Mar 15	2,199	179	696	93
31 Dec 14	2,263	178	733	89
30 Sep 14	2,242	199	678	91
30 Jun 14	2,181	164	655	87
31 Mar 14	2,107	149	645	79
31 Dec 13	2,017	133	589	80
30 Sep 13	2,015	120	555	76

Guadagni di qualità: 4106 ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di 4106 (4.5%) sono inferiori rispetto allo scorso anno (6.5%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di 4106 sono cresciuti del 11% all'anno negli ultimi 5 anni.

Accelerare la crescita: 4106 ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: 4106 ha avuto una crescita negativa degli utili ( -38.1% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Medical Equipment ( 3.5% ).

Wellell Performance dei guadagni passati

Il passato criteri di controllo 2/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Second quarter 2024 earnings released: EPS: NT$0.21 (vs NT$0.50 in 2Q 2023)

Wellell Inc. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: NT$0.40 (vs NT$0.50 in 1Q 2023)

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Recent updates

New minor risk - Profit margin trend

Second quarter 2024 earnings released: EPS: NT$0.21 (vs NT$0.50 in 2Q 2023)

Wellell Inc. to Report Q2, 2024 Results on Aug 13, 2024

Upcoming dividend of NT$0.80 per share

Wellell's (TWSE:4106) Dividend Is Being Reduced To NT$0.80

Wellell (TWSE:4106) Has Announced That Its Dividend Will Be Reduced To NT$0.80

Dividend reduced to NT$0.80

Wellell Inc. Approves Common Stock Cash Dividend, Payable on August 26, 2024

First quarter 2024 earnings released: EPS: NT$0.40 (vs NT$0.50 in 1Q 2023)

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer

Full year 2023 earnings released: EPS: NT$1.51 (vs NT$1.60 in FY 2022)

Wellell Inc., Annual General Meeting, Jun 24, 2024

Wellell Inc. Appoints Lee Pi Kai as Chief Strategy Officer

Wellell Inc. Announces Resignation of Tan, Jian-Qiang as Chief Operating Officer

Second quarter 2023 earnings released: EPS: NT$0.50 (vs NT$0.51 in 2Q 2022)

Upcoming dividend of NT$0.85 per share at 2.7% yield

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 16%

Wellell Inc. Appoints Shin-Ho,Chen as Corporate Governance Officer

Full year 2022 earnings released: EPS: NT$1.60 (vs NT$1.01 in FY 2021)

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$0.59 (vs NT$0.31 in 3Q 2021)

Insufficient new directors

Wellell Inc. Announces Change Member of Remuneration Committee

Second quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.34 in 2Q 2021)

Insufficient new directors

Apex Medical Corp. Approves Cash Dividend for the Year 2021

Apex Medical Corp. Announces Change of Alan Chang as Research and Development Officer, Effective May 31, 2022

Apex (Kunshan)Medical Corp. to Announce Production Can Be Resume Gradually

Apex Medical Corp. Announces On Behalf of the Subsidiaries Apex (Kunshan) Medical Corp. and Wellell (Kunshan) Co., Ltd. Extend Temporary Suspension of Production

Wellell (Kunshan) Co., Ltd. Announces the Temporary Suspension of Production

Full year 2021 earnings released: EPS: NT$1.01 (vs NT$1.04 in FY 2020)

Wellell Inc., Annual General Meeting, Jun 20, 2022

Third quarter 2021 earnings released: EPS NT$0.31 (vs NT$0.28 in 3Q 2020)

High number of new directors

High number of new directors

High number of new directors

Upcoming dividend of NT$0.55 per share

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.55 in 2Q 2020)

High number of new directors

High number of new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$0.29 (vs NT$0.074 in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$1.04 (vs NT$0.87 in FY 2019)

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Apex Medical Corp. Announces Executive Changes, Effective March 01, 2021

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Apex Medical Corp. Appoints Alan Chang as Director of R&D

New 90-day low: NT$25.65

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Is Apex Medical (TPE:4106) Using Too Much Debt?

New 90-day low: NT$28.00

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

New 90-day low: NT$28.90

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Third quarter 2020 earnings released: EPS NT$0.28

New 90-day low: NT$31.05

First half earnings released

Ripartizione dei ricavi e delle spese

Storia dei guadagni e delle entrate

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato